Jeremy Grantham Spectrum Pharmaceuticals Inc Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$16.09 - $23.07 $347,544 - $498,312	-21,600 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $84,168 - $130,599	6,300 Added 41.18%	21,600 $409,000
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $133,875 - $215,271	15,300	15,300 $215,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.